Stuthi P. Perimbeti

Oncology
500 University Dr
Hershey, PA 17033

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 23 publications

Computational pathology features of immune architecture predict clinically relevant outcomes in small-cell lung cancer (SCLC).

Computational pathology features of immune architecture predict clinically relevant outcomes in small-cell lung cancer (SCLC).

Journal: NPJ precision oncology
Published: August 05, 2025

Phase Ib study of enzalutamide with venetoclax in patients with metastatic castration-resistant prostate cancer.

Phase Ib study of enzalutamide with venetoclax in patients with metastatic castration-resistant prostate cancer.

Journal: Cancer chemotherapy and pharmacology
Published: May 23, 2025

Phase Ib Study of Enzalutamide with Venetoclax in Patients with Metastatic Castration-Resistant Prostate Cancer.

Phase Ib Study of Enzalutamide with Venetoclax in Patients with Metastatic Castration-Resistant Prostate Cancer.

Journal: medRxiv : the preprint server for health sciences
Published: May 02, 2025

Management options for node-positive muscle-invasive bladder cancer.

Management options for node-positive muscle-invasive bladder cancer.

Journal: Clinical advances in hematology & oncology : H&O
Published: October 02, 2024

Angelica gigas Nakai (Korean Dang-gui) Root Alcoholic Extracts in Health Promotion and Disease Therapy - active Phytochemicals and In Vivo Molecular Targets.

Angelica gigas Nakai (Korean Dang-gui) Root Alcoholic Extracts in Health Promotion and Disease Therapy - active Phytochemicals and In Vivo Molecular Targets.

Journal: Pharmaceutical research
Published: September 20, 2024

Psychological Distress, Emergency Room Utilization, and Mortality Risk Among US Adults With History of Prostate Cancer.

Psychological Distress, Emergency Room Utilization, and Mortality Risk Among US Adults With History of Prostate Cancer.

Journal: JCO oncology practice
Published: January 30, 2024

Patients' Preferences for Adjuvant Osimertinib in Non-Small-Cell Lung Cancer After Complete Surgical Resection: What Makes It Worth It to Patients?

Patients' Preferences for Adjuvant Osimertinib in Non-Small-Cell Lung Cancer After Complete Surgical Resection: What Makes It Worth It to Patients?

Journal: Clinical lung cancer
Published: January 28, 2024

Risk of Further Progression or Death Among Durable Progression-Free Survivors With Melanoma or Non-Small-Cell Lung Cancer in PD-1 Blockade Trials: Implications for Imaging Surveillance.

Risk of Further Progression or Death Among Durable Progression-Free Survivors With Melanoma or Non-Small-Cell Lung Cancer in PD-1 Blockade Trials: Implications for Imaging Surveillance.

Journal: JCO oncology practice
Published: September 08, 2023

Oncotype Dx Score, HER2 Low Expression, and Clinical Outcomes in Early-Stage Breast Cancer: A National Cancer Database Analysis.

Oncotype Dx Score, HER2 Low Expression, and Clinical Outcomes in Early-Stage Breast Cancer: A National Cancer Database Analysis.

Journal: Cancers
Published: August 02, 2023

Medicaid expansion and racial disparity in timely multidisciplinary treatment in muscle invasive bladder cancer.

Medicaid expansion and racial disparity in timely multidisciplinary treatment in muscle invasive bladder cancer.

Journal: Journal of the National Cancer Institute
Published: March 04, 2023

Transportation barriers, emergency room use, and mortality risk among US adults by cancer history.

Transportation barriers, emergency room use, and mortality risk among US adults by cancer history.

Journal: Journal of the National Cancer Institute
Published: November 21, 2022

Trends, Burden, and Impact of Arrhythmias on Cardiac Transplant Recipients: A 16-year Nationwide Study.

Trends, Burden, and Impact of Arrhythmias on Cardiac Transplant Recipients: A 16-year Nationwide Study.

Journal: Current problems in cardiology
Published: October 31, 2022
Showing 1-12 of 23

Last Updated: 09/26/2026